Global Information
회사소개 | 문의 | 위시리스트

세계의 수면 중 이갈이 치료 시장 : 예측

Global Sleeping Bruxism Treatment Market Research Report - Forecast to 2023

리서치사 Market Research Future
발행일 2018년 07월 상품 코드 682755
페이지 정보 영문 151 Pages
가격
US $ 4,450 ₩ 5,477,000 Unprintable PDF by E-mail (Single User License)
US $ 6,250 ₩ 7,692,000 Printable PDF by E-mail (Corporate User License)


세계의 수면 중 이갈이 치료 시장 : 예측 Global Sleeping Bruxism Treatment Market Research Report - Forecast to 2023
발행일 : 2018년 07월 페이지 정보 : 영문 151 Pages

세계의 수면 중 이갈이(Sleeping Bruxism) 치료 시장에 대해 조사분석했으며, 시장 역학, 시장 동향, 부문·지역별 시장 분석, 경쟁 구도, 주요 기업 등의 정보를 정리하여 전해드립니다.

제1장 조사 프롤로그

제2장 시장 서론

제3장 조사 방법

제4장 시장 역학

  • 서론
  • 촉진요인
  • 억제요인
  • 기회
  • 거시경제 지표

제5장 시장 요인 분석

  • 밸류체인 분석
  • Porter의 산업 분석
  • 투자 기회
  • 가격 분석

제6장 세계의 수면 중 이갈이 치료 시장 : 종류별

  • 서론
  • 일차성 이갈이
  • 2차성 이갈이

제7장 세계의 수면 중 이갈이 치료 시장 : 진단별

  • 서론
    • 임상 검사
    • X선
    • 근전도 측정
    • 수면다원 검사

제8장 세계의 수면 중 이갈이 치료 시장 : 치료 종류별

  • 서론
  • 치과 접근
  • 약제

제9장 세계의 수면 중 이갈이 치료 시장 : 원인별

  • 서론
  • 폐쇄성 수면무호흡(OSA)
  • 위식도 역류증(GERD)
  • 부정교합
  • 수면 마비

제10장 세계의 수면 중 이갈이 치료 시장 : 환자 종류별

  • 서론
  • 소아
  • 성인

제11장 세계의 수면 중 이갈이 치료 시장 : 최종사용자별

  • 서론
  • 병원
  • 치과 클리닉

제12장 세계의 수면 중 이갈이 치료 시장 : 지역별

  • 서론
  • 아메리카
  • 유럽
  • 아시아태평양
  • 중동·아프리카

제13장 경쟁 분석

  • 서론

제14장 기업 개요

  • Ivoclar Vivadent AG
  • Ipsen Biopharmaceuticals, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Carestream Dental
  • Akervall Technologies Inc.
  • PLANMECA OY
  • Randmark Dental Products, LLC
  • S4S Dental Laboratory
  • Patterson Dental Supply, Inc.
  • Henry Schein, Inc.
  • Pfizer Inc.

제15장 부록

KSA 18.08.31

List of Tables

  • TABLE 1 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 2 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR PRIMARY BRUXISM 2015-2023 (USD MILLION)
  • TABLE 3 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR SECONDARY BRUXISM 2015-2023 (USD MILLION)
  • TABLE 4 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 5 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR DENTAL APPROACHES 2015-2023 (USD MILLION)
  • TABLE 6 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR MEDICATION 2015-2023 (USD MILLION)
  • TABLE 7 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 8 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR OBSTRUCTIVE SLEEP APNEA 2015-2023 (USD MILLION)
  • TABLE 9 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) 2015-2023 (USD MILLION)
  • TABLE 10 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR MALOCCLUSION 2015-2023 (USD MILLION)
  • TABLE 11 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR SLEEP PARALYSIS 2015-2023 (USD MILLION)
  • TABLE 12 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 13 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR PEDIATRIC 2015-2023 (USD MILLION)
  • TABLE 14 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR ADULT 2015-2023 (USD MILLION)
  • TABLE 15 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 16 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR HOSPITALS 2015-2023 (USD MILLION)
  • TABLE 17 GLOBAL SLEEPING BRUXISM TREATMENT MARKET FOR DENTAL CLINICS 2015-2023 (USD MILLION)
  • TABLE 18 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 19 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 20 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 21 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 22 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 23 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 24 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 25 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 26 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 27 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 28 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 29 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 30 U.S SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 31 U.S SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 32 U.S SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 33 U.S SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 34 U.S SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 35 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 36 CANADA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 37 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 38 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 39 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 40 SOUTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION).
  • TABLE 41 SOUTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 42 SOUTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 43 SOUTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 44 SOUTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 45 EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 46 EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 47 EUROPE SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 48 EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 49 EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 50 EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 51 WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 52 WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 53 WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 54 WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 55 WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 56 GERMANY SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 57 GERMANY SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 58 GERMANY SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 59 GERMANY SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 60 GERMANY SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 61 FRANCE SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 62 FRANCE SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 63 FRANCE SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 64 FRANCE SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 65 FRANCE SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 66 U.K SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 67 U.K SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 68 U.K SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 69 U.K SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 70 U.K SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 71 SCANDINAVIA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 72 SCANDINAVIA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 73 SCANDINAVIA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 74 SCANDINAVIA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 75 SCANDINAVIA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 76 DENMARK SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 77 DENMARK SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 78 DENMARK SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 79 DENMARK SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 80 DENMARK SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 81 NORWAY SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 82 NORWAY SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 83 NORWAY SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 84 NORWAY SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 85 NORWAY SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 86 SWEDEN SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 87 SWEDEN SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 88 SWEDEN SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 89 SWEDEN SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 90 SWEDEN SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 91 FINLAND SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 92 FINLAND SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 93 FINLAND SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 94 FINLAND SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 95 FINLAND SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 96 ICELAND SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 97 ICELAND SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 98 ICELAND SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 99 ICELAND SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 100 ICELAND SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 101 BENELUX UNION SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 102 BENELUX UNION SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 103 BENELUX UNION SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 104 BENELUX UNION SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 105 BENELUX UNION SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 106 BELGIUM SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 107 BELGIUM SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 108 BELGIUM SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 109 BELGIUM SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 110 BELGIUM SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 111 NETHERLANDS SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 112 NETHERLANDS SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 113 NETHERLANDS SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 114 NETHERLANDS SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 115 NETHERLANDS SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 116 LUXEMBOURG SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 117 LUXEMBOURG SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 118 LUXEMBOURG SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 119 LUXEMBOURG SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 120 LUXEMBOURG SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 121 ITALY SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 122 ITALY SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 123 ITALY SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 124 ITALY SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 125 ITALY SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 126 SPAIN SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 127 SPAIN SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 128 SPAIN SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 129 SPAIN SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 130 SPAIN SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 131 SWITZERLAND SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 132 SWITZERLAND SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 133 SWITZERLAND SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 134 SWITZERLAND SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 135 SWITZERLAND SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 136 REST OF WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 137 REST OF WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 138 REST OF WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 139 REST OF WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 140 REST OF WESTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 141 EASTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 142 EASTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 143 EASTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 144 EASTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 145 EASTERN EUROPE SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 146 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 147 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET SHARE BY REGION 2017 (%)
  • TABLE 148 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 149 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 150 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 151 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 152 ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 153 CHINA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 154 CHINA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 155 CHINA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 156 CHINA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 157 CHINA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 158 INDIA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 159 INDIA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 160 INDIA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 161 INDIA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 162 INDIA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 163 JAPAN SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 164 JAPAN SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 165 JAPAN SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 166 JAPAN SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 167 JAPAN SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 168 SOUTH KOREA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 169 SOUTH KOREA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 170 SOUTH KOREA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 171 SOUTH KOREA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 172 SOUTH KOREA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 173 REST OF ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 174 REST OF ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 175 REST OF ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 176 REST OF ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 177 REST OF ASIA PACIFIC SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 178 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET SHARE BY REGION 2017 (%)
  • TABLE 180 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 181 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 182 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 183 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 184 MIDDLE EAST & AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 185 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 186 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 187 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 188 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 189 MIDDLE EAST SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 190 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2015-2023 (USD MILLION)
  • TABLE 191 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BYTREATMENT TYPE 2015-2023 (USD MILLION)
  • TABLE 192 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2015-2023 (USD MILLION)
  • TABLE 193 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE 2015-2023 (USD MILLION)
  • TABLE 194 AFRICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 195 TOP MANUFACTURERS IN THE GLOBAL SLEEPING BRUXISM TREATMENT MARKET

List of Figures

  • FIGURE 1 MARKET STRUCTURE
  • FIGURE 2 RESEARCH PROCESS
  • FIGURE 3 DROC ANALYSIS OF THE GLOBAL SLEEPING BRUXISM TREATMENT MARKET
  • FIGURE 4 DRIVERS IMPACT ANALYSIS: GLOBAL SLEEPING BRUXISM TREATMENT MARKET
  • FIGURE 5 RESTRAINTS IMPACT ANALYSIS: GLOBAL SLEEPING BRUXISM TREATMENT MARKET
  • FIGURE 6 VALUE CHAIN: GLOBAL SLEEPING BRUXISM TREATMENT MARKET
  • FIGURE 7 PORTER'S FIVE FORCES MODEL: GLOBAL SLEEPING BRUXISM TREATMENT MARKET
  • FIGURE 8 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TYPE 2017 & 2023
  • FIGURE 9 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT TYPE 2017 & 2023
  • FIGURE 10 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2017 & 2023
  • FIGURE 11 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2017 & 2023
  • FIGURE 12 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE 2017 & 2023
  • FIGURE 13 GLOBAL SLEEPING BRUXISM TREATMENT MARKET SHARE BY REGION 2017 (%)
  • FIGURE 14 AMERICAS SLEEPING BRUXISM TREATMENT MARKET SHARE BY REGION 2017 (%)
  • FIGURE 15 EUROPE SLEEPING BRUXISM TREATMENT MARKET SHARE BY REGION 2017 (%)

Introduction

Sleep bruxism or nocturnal tooth grinding is a medical condition indicated by the clenching or grinding of teeth during sleep. The global sleeping bruxism treatment market is estimated to be driven by the increasing prevalence of sleep bruxism, growth in child population, changing lifestyle, and rising prevalence of obstructive sleep apnea. Sleep bruxism is a sleep-related movement disorder, characterized by teeth grinding and jaw clenching during sleep. Since the past few years, it has been reported that the prevalence of the disease has increased. According to a study published by the Sleep Research Society, the general prevalence of sleep bruxism was estimated to range from 5.0 to 8.0% in 2016. In the presence of such trends, the reported cases of headaches and tooth wear due to sleep bruxism are estimated to increase, thereby, mounting a negative impact on patients' lives. Few effective ways to avoid such complications associated with the disease include the administration of medication, antidepressants, and muscle relaxants and wearing a mouth guard, besides others. Thus, it is estimated that the increasing prevalence of sleep bruxism is subsequently increasing the demand for available therapeutic options involving antidepressants, muscle relaxants, and mouth guard, besides others. Conclusively, it is expected to provide favorable backgrounds for the market to grow during the forecast period.

However, factors such as the limited availability of treatment options and the high cost of custom fit night guards restrain the market growth. There is no specific cure, i.e., medications are not very effective for the treatment of sleep bruxism. In such circumstances, it becomes important to manage the consequences of the disorder by available preventative measures, which involves the application of mandibular advancement devices, occlusal splints, stress management, drugs, occlusal splints, and others. A variety of medications such as anti-anxiety drugs and muscle relaxants are significantly employed in the treatment of sleep bruxism. However, it is reported that such medication options come with the capping of side effects such as constipation, nausea, and muscle weakness, amongst others. Following the same course, it is evident that bruxism mouth-guards ground down with time during bruxism episodes. Thus, it is estimated that available treatment options are not effective and incorporate side effects, making the patients reluctant to opt for available treatment options. This makes the market to lag during the study.

The global sleeping bruxism treatment market is estimated to reach USD 168.74 million by 2023, from USD 118.02 million in 2017. The market is projected to register a CAGR of 6.1%, during the forecast period from 2018 to 2023.

The sleeping bruxism treatment market comprises a variety of products. Based on the treatment type, the global market for sleeping bruxism treatments is segmented into primary bruxism and secondary bruxism. In primary bruxism, the chewing muscle activity and the autonomic nervous system is triggered by sleep arousals that eventually lead to teeth grinding. The primary bruxism segment held the largest market share and is estimated to reach USD 168.74 million by 2023 from USD 118.02 million in 2017.

The global sleeping bruxism treatment market is segmented into diagnosis types which are inclusive of clinical examination, electromyographic methods, polysomnography, x-ray, and others.

Based on treatment, the global sleeping bruxism treatment market is segmented into dental approaches and medication. Dental approaches are the first line treatment given to the patients of sleeping bruxism and include splints and mouth guards. Thus, dental approaches account for the largest market share.

Based on the cause, the global sleeping bruxism treatment market is segmented into obstructive sleep apnea, sleep paralysis, Gastro-Esophageal Reflux Disease (GERD) malocclusion, and others. Obstructive sleep apnea is a sleep disorder that is characterized by repetitive breathing interruption in sleep. According to the National Sleep Foundation, one in four people with obstructive sleep apnea, clench their teeth in sleep. Thus, obstructive sleep apnea is one of the major causes of sleeping bruxism and held the largest segment in 2017.

Based on its patient type, the global sleeping bruxism treatment market is segmented into pediatric and adult. Sleep bruxism occurs in children when they are taking a sound sleep and are under stress. Anger and nervousness lead to bruxism in kids. According to KidsHealth, three out of every ten children suffer from sleep bruxism. Hence, the pediatric segment is estimated to hold the largest market share during the forecast period.

On the basis of end-user, the global sleeping bruxism treatment market is segmented into hospitals, dental clinics, and others. Dental clinics offer mouth guards, splints, orthodontic treatment and dental corrections. The increased use of dental approaches for teeth restoration accounts for a major market share of the sleep bruxism treatment market.

Key Players

The key players for the sleeping bruxism treatment market include Randmark Dental Products, LLC, S4S Dental Laboratory, Ipsen Biopharmaceuticals, Inc, Merz Pharma GmbH & Co. KGaA, Carestream Dental, PLANMECA OY, and others.

Study Objectives

  • To provide historical and forecast revenue of market segments and sub-segments with respect to regional markets and their countries
  • To provide insights into factors influencing and affecting the market growth
  • To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
  • To provide economic factors that influence the global sleeping bruxism treatment market

Target Audience

  • Pharmaceutical and Medical Device Industries
  • Potential Investors
  • Medical Research Institutes
  • Key Executives (CEO and COO) and Strategy Growth Managers
  • Research Companies

Key Findings

  • The major market players in the global sleeping bruxism treatment market are Randmark Dental Products, LLC, S4S Dental Laboratory, and Ipsen Biopharmaceuticals, Inc
  • Based on type, the primary bruxism segment held the largest market share and is estimated to reach USD 168.74 million by 2023 from USD 118.02 million in 2017.
  • On the basis of treatment type, dental approaches account for the largest market share and are estimated to register a CAGR of 7.0% from 2018 to 2023
  • Based on cause, the obstructive sleep apnea market is projected to reach USD 233.20 million by the end of 2023.

The report also covers regional analysis

Americas

  • North America
    • US
    • Canada
  • South America

Europe

  • Western Europe
    • Germany
    • France
    • UK
    • Scandinavia
  • Denmark
  • Norway
  • Sweden
  • Finland
  • Iceland
    • Benelux Union
  • Belgium
  • Netherlands
  • Luxembourg
    • Italy
    • Spain
    • Switzerland
  • Eastern Europe

Asia-Pacific

    • China
    • India
    • Japan
    • South Korea
    • Rest of the Asia-Pacific

Middle East & Africa

  • Middle East
  • Africa

Table of Contents

1 Report Prologue

2 Market Introduction

  • 2.1 Introduction
  • 2.2 Assumptions & Limitations

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation
  • 3.5 Data Triangulation

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Increasing prevalence of sleep bruxism
    • 4.2.2 Growing child population
    • 4.2.3 Rising prevalence of obstructive sleep apnea
    • 4.2.4 Lifestyle changes
    • 4.2.5 Drivers Impact Analysis
  • 4.3 Restraints
    • 4.3.1 Limited availability of treatment options
    • 4.3.2 High cost of custom fit night guards
    • 4.3.3 Restraints Impact Analysis
  • 4.4 Opportunity
    • 4.4.1 Untapped markets of the Asia Pacific region
  • 4.5 Macroeconomic Indicator

5 Market Factor Analysis

  • 5.1 Value Chain Analysis
    • 5.1.1 R&D and Designing
    • 5.1.2 Manufacturing
    • 5.1.3 Distribution & Sales
    • 5.1.4 Post-Sales Review

  • 5.2 Porter's Five Forces Model
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Buyers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitutes
    • 5.2.5 Intensity of Rivalry
  • 5.3 Investment Opportunities
  • 5.4 Pricing Analysis

6 Global Sleeping Bruxism Treatment Market, by Type

  • 6.1 Introduction
  • 6.2 Primary Bruxism
  • 6.3 Secondary Bruxism

7 Global Sleeping Bruxism Treatment Market, by Diagnosis

  • 7.1 Introduction
    • 7.1.1 Clinical Examination
    • 7.1.2 X-rays
    • 7.1.3 Electromyographic Methods
    • 7.1.4 Polysomnography

8 Global Sleeping Bruxism Treatment Market, by Treatment Type

  • 8.1 Introduction
  • 8.2 Dental Approaches
  • 8.3 Medication

9 Global Sleeping Bruxism Treatment Market, by Cause

  • 9.1 Introduction
  • 9.2 Obstructive Sleep Apnea
  • 9.3 Gastroesophageal reflux disease (GERD)
  • 9.4 Malocclusion
  • 9.5 Sleep Paralysis

10 Global Sleeping Bruxism Treatment Market, by Patient Type

  • 10.1 Introduction
  • 10.2 Pediatric
  • 10.3 Adult

11 Global Sleeping Bruxism Treatment Market, by End-User

  • 11.1 Introduction
  • 11.2 Hospitals
  • 11.3 Dental Clinics

12 Global Sleeping Bruxism Treatment Market, by Region

  • 12.1 Introduction
  • 12.2 Americas
    • 12.2.1 North America
      • 12.2.1.1 US
      • 12.2.1.2 Canada
    • 12.2.2 South America
  • 12.3 Europe
    • 12.3.1 Introduction
    • 12.3.2 Western Europe
      • 12.3.2.1 Germany
      • 12.3.2.2 France
      • 12.3.2.3 U.K
      • 12.3.2.4 Scandinavia
      • 12.3.2.4.1 Denmark
      • 12.3.2.4.2 Norway
      • 12.3.2.4.3 Sweden
      • 12.3.2.4.4 Finland
      • 12.3.2.4.5 Iceland
      • 12.3.2.5 Benelux Union
      • 12.3.2.5.1 Belgium
      • 12.3.2.5.2 Netherlands
      • 12.3.2.5.3 Luxembourg
      • 12.3.2.6 Italy
      • 12.3.2.7 Spain
      • 12.3.2.8 Switzerland
    • 12.3.3 Eastern Europe
  • 12.4 Asia Pacific
    • 12.4.1 Introduction
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Japan
    • 12.4.5 South Korea
    • 12.4.6 Rest of Asia Pacific
  • 12.5 Middle East & Africa
    • 12.5.1 Introduction
    • 12.5.2 Middle East
    • 12.5.3 Africa

13 Competitive Analysis

  • 13.1 Introduction

14 Company Profiles

  • 14.1 Ivoclar Vivadent AG
    • 14.1.1 Company Overview
    • 14.1.2 Financial Overview
    • 14.1.3 Products Offering
    • 14.1.4 Key Developments
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Strategy
  • 14.2 Ipsen Biopharmaceuticals, Inc.
    • 14.2.1 Company Overview
    • 14.2.2 Financial Overview
    • 14.2.3 Products Offering
    • 14.2.4 Key Developments
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Strategy
  • 14.3 Merz Pharma GmbH & Co. KGaA
    • 14.3.1 Company Overview
    • 14.3.2 Financial Overview
    • 14.3.3 Products Offering
    • 14.3.4 Key Developments
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Strategy
  • 14.4 Carestream Dental
    • 14.4.1 Company Overview
    • 14.4.2 Financial Overview
    • 14.4.3 Products Offering
    • 14.4.4 Key Developments
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Strategy
  • 14.5 Akervall Technologies Inc.
    • 14.5.1 Company Overview
    • 14.5.2 Financial Overview
    • 14.5.3 Products Offering
    • 14.5.4 Key Developments
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Strategy
  • 14.6 PLANMECA OY
    • 14.6.1 Company Overview
    • 14.6.2 Financial Overview
    • 14.6.3 Products Offering
    • 14.6.4 Key Developments
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Strategy
  • 14.7 Randmark Dental Products, LLC
    • 14.7.1 Company Overview
    • 14.7.2 Financial Overview
    • 14.7.3 Products Offering
    • 14.7.4 Key Developments
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Strategy
  • 14.8 S4S Dental Laboratory
    • 14.8.1 Company Overview
    • 14.8.2 Financial Overview
    • 14.8.3 Products Offering
    • 14.8.4 Key Developments
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Strategy
  • 14.9 Patterson Dental Supply, Inc.
    • 14.9.1 Company Overview
    • 14.9.2 Financial Overview
    • 14.9.3 Products Offering
    • 14.9.4 Key Developments
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Strategy
  • 14.1 Henry Schein, Inc.
    • 14.10.1 Company Overview
    • 14.10.2 Financial Overview
    • 14.10.3 Products Offering
    • 14.10.4 Key Developments
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Strategy
  • 14.11 Pfizer Inc.
    • 14.11.1 Company Overview
    • 14.11.2 Financial Overview
    • 14.11.3 Products Offering
    • 14.11.4 Key Developments
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Strategy

15 Appendix

  • 15.1 Discussion Blue Print
Back to Top
전화 문의
F A Q